Olaparib (O) in patients (pts) with colorectal cancer (CRC) with ATM mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study.

Authors :: Behl, Deepti
Rothe, Michael
Mangat, Pam K.
Garrett-Mayer, Elizabeth
Farrington, Laura Catherine
Crysler, Oxana V.
Dib, Elie G.
Duvivier, Herbert Leon
Hall, Michael J.
Salmon, John Stuart
Alese, Olatunji B.
Marr, Alissa S.
Ngirailemesang, Isa
Polavaram, Latha
Thota, Ramya
Yang, Eddy Shih-Hsin
O'Lone, Raegan
Grantham, Gina N.
Halabi, Susan
Schilsky, Richard L.
Source :: Journal of Clinical Oncology; 2/1/2023 Supplement 1, Vol. 41, p122-122, 1p
Publication Year :: 2023

Full Text Access

Tools